Literature DB >> 22353486

Inositol 1,4,5-tripshosphate receptor, calcium signaling, and polyglutamine expansion disorders.

Ilya Bezprozvanny.   

Abstract

Entities:  

Year:  2010        PMID： 22353486      PMCID： PMC4996668          DOI： 10.1016/S1063-5823(10)66014-0

Source DB:  PubMed          Journal:  Curr Top Membr        ISSN： 1063-5823            Impact factor:   3.049


× No keyword cloud information.
  120 in total

1.  Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening.

Authors:  Y Nagai; T Tucker; H Ren; D J Kenan; B S Henderson; J D Keene; W J Strittmatter; J R Burke
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

2.  Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.

Authors:  Dagmar E Ehrnhoefer; Martin Duennwald; Phoebe Markovic; Jennifer L Wacker; Sabine Engemann; Margaret Roark; Justin Legleiter; J Lawrence Marsh; Leslie M Thompson; Susan Lindquist; Paul J Muchowski; Erich E Wanker
Journal:  Hum Mol Genet       Date:  2006-08-07       Impact factor: 6.150

Review 3.  Neuronal calcium signaling.

Authors:  M J Berridge
Journal:  Neuron       Date:  1998-07       Impact factor: 17.173

4.  Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.

Authors:  Y Sun; A Savanenin; P H Reddy; Y F Liu
Journal:  J Biol Chem       Date:  2001-04-23       Impact factor: 5.157

5.  Loss of endoplasmic reticulum-associated enzymes in affected brain regions in Huntington's disease and Alzheimer-type dementia.

Authors:  A J Cross; T J Crow; J A Johnson; J M Dawson; T J Peters
Journal:  J Neurol Sci       Date:  1985-12       Impact factor: 3.181

Review 6.  Lessons from animal models of Huntington's disease.

Authors:  David C Rubinsztein
Journal:  Trends Genet       Date:  2002-04       Impact factor: 11.639

7.  Widespread expression of inositol 1,4,5-trisphosphate receptor type 1 gene (Insp3r1) in the mouse central nervous system.

Authors:  T Furuichi; D Simon-Chazottes; I Fujino; N Yamada; M Hasegawa; A Miyawaki; S Yoshikawa; J L Guénet; K Mikoshiba
Journal:  Receptors Channels       Date:  1993

8.  Riluzole in Huntington's disease: a 3-year, randomized controlled study.

Authors:  G Bernhard Landwehrmeyer; Bruno Dubois; Justo Garcia de Yébenes; Berry Kremer; Wilhelm Gaus; Peter H Kraus; Horst Przuntek; Michel Dib; Adam Doble; Wilhelm Fischer; Albert C Ludolph
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

9.  Widespread expression of Huntington's disease gene (IT15) protein product.

Authors:  A H Sharp; S J Loev; G Schilling; S H Li; X J Li; J Bao; M V Wagster; J A Kotzuk; J P Steiner; A Lo
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

10.  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses.

Authors:  Sofia Papadia; Francesc X Soriano; Frédéric Léveillé; Marc-Andre Martel; Kelly A Dakin; Henrik H Hansen; Angela Kaindl; Marco Sifringer; Jill Fowler; Vanya Stefovska; Grahame McKenzie; Marie Craigon; Roderick Corriveau; Peter Ghazal; Karen Horsburgh; Bruce A Yankner; David J A Wyllie; Chrysanthy Ikonomidou; Giles E Hardingham
Journal:  Nat Neurosci       Date:  2008-03-23       Impact factor: 24.884
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.